PASSION Trial Protocol Version 1
SEEK ID: https://ldh.kks-marburg.imise.uni-leipzig.de/documents/1?version=1
Filename: Passion_Prüfplan_V04F_2021-07-07_KKSN.pdf
Format: PDF document
Size: 697 KB
Export PNG
Download
Creators and SubmitterViews: 83 Downloads: 0
Created: 25th Nov 2024 at 10:30
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 (earliest) Created 25th Nov 2024 at 10:30 by Gerrit zur Hausen
No revision comments
Related items
Trial Projects:
- Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION)
- Lymphadenectomy in Ovarian Neoplasms (LION)
- Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-pem)
- A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA
- A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer
- Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
Institutions: Philipps-University Marburg, Coordinating Center for Clinical Trials
https://orcid.org/0009-0009-8967-7299
Trial Projects:
- Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION)
- Lymphadenectomy in Ovarian Neoplasms (LION)
- Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-pem)
- A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA
- A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer
- Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
Web page: Not specified
A randomized, placebo-controlled, double-blind, parallel group, multi-center, phase III trial to address treatment options for combined post- and pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction
Sponsor: Philipps-University Marburg
Public web page: Not specified
Start date: 20th Jun 2020
End date: 30th Jun 2023
